NEVVI Medicare utilization intelligence

CMS RBCS · Imaging · Standard X-ray

Contrast Agent codes

20 CPT®/HCPCS codes, ranked by est. all-Medicare services — scaled from national Medicare Part B fee-for-service volume. Open any code for the full market view — ranked physician groups, geography, and 12-year trend.

CY2024 · National scale is an all-Medicare estimate · est. — scaled estimate — assumes MA utilization mirrors FFS; not an observation; the observed fee-for-service figure is shown adjacent. Part B · national figures

HCPCS · Standard X-ray imaging Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 192.06M services · est. ▲ 5.4% YoY · 1.04M FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 95.20M observed fee-for-service services

See the national market for Q9967 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 7.71M services · est. ▼ 6.4% YoY · 143,439 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 3.74M observed fee-for-service services

See the national market for Q9966 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 5.01M services · est. ▲ 46.9% YoY · 24,731 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 2.14M observed fee-for-service services

See the national market for Q9965 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9957 Injection, perflutren lipid microspheres, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 149,807 services · est. ▲ 16.9% YoY · 38,592 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 72,795 observed fee-for-service services

See the national market for Q9957 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 80,480 services · est. · 199 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 40,141 observed fee-for-service services

See the national market for Q9958 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 60,916 services · est. ▲ 11.1% YoY · 2,297 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 29,755 observed fee-for-service services

See the national market for Q9968 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9956 Injection, octafluoropropane microspheres, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 30,403 services · est. ▼ 4.7% YoY · 5,302 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 14,280 observed fee-for-service services

See the national market for Q9956 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 14,303 services · est. · 285 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 6,840 observed fee-for-service services

See the national market for Q9961 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 9,145 services · est. · 427 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 4,561 observed fee-for-service services

See the national market for Q9963 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 3,619 services · est. ▲ 30.5% YoY · 570 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 1,805 observed fee-for-service services

See the national market for Q9960 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 1,269 services · est. ▲ 1.5% YoY · 240 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 633 observed fee-for-service services

See the national market for Q9962 → ranked groups · states · 12-yr trend

HCPCS · Standard X-ray imaging Q9954 Oral magnetic resonance contrast agent, per 100 ml CMS descriptor · HCPCS
Medicare Part B claims

First observed 2013 — start of our 12-year window; the code predates it

National scale 938 services · est. ▼ 25.9% YoY · 108 FFS beneficiary-episodes (CY2022, all-Medicare estimate) — 508 observed fee-for-service services

See the national market for Q9954 → ranked groups · states · 12-yr trend

8 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.